5-chloro-3-{[(4-chlorophenyl)methyl]sulfanyl}-1,2,4-thiadiazole, 95.0%, 1g

1-(2-methoxyphenyl)-1H-imidazole-2-thiol, 95.0%, 500mg

4,6-dioxo-1,4,5,6-tetrahydro-1,3,5-triazine-2-carboxamide, 95+%, 250mg

6-Bromo-4-methoxypyridin-2-amine, 95.0%, 1g

1H-Benzotriazol-1-yloxytripyrrolidinophosphonium Hexafluorophosphate [Coupling Reagent for Peptide]>98.0%(HPLC)5g

1-(BENZENESULFONYL)-4-BROMO-6-FLUORO-1H-INDOLE, 95.0%, 10g

N-benzyl-2-methylpropan-1-amine, 95.0%, 2.5g

1,4-Di(oxiran-2-yl)butane, 95.0%, 10g

3-CYCLOPROPYL-1H-PYRAZOLE-4-CARBOXYLIC ACID, 95.0%, 1g

GC capillary column ROTI®Cap-1, 25 m, 0.25 mm, 0.10 µm, 1 Piece(s)

Bis(pentafluorophenyl)dimethoxysilane, 97%, 25g

5-Phenyl-n-valeric acid methyl ester, 97%, 5g

3-(1H-Pyrrol-1-yl)propan-1-ol, 95.0%, 100mg